The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

• Autores principales: Ohoud Aljuhani (Autor), Ghazwa B. Korayem (Autor), Ali F. Altebainawi (Autor), Meshal S. Alotaibi (Autor), Noura A. Alrakban (Autor), Ragia H. Ghoneim (Autor), Ramesh Vishwakarma (Autor), Abdulrahman I. Al Shaya (Autor), Shmeylan Al Harbi (Autor), Jawaher Gramish (Autor), Dahlia M. Almutairi (Autor), Ghada Alqannam (Autor), Faisal F. Alamri (Autor), Abdullah F. Alharthi (Autor), Mashael Alfaifi (Autor), Abdullah Al Amer (Autor), Abeer A. Alenazi (Autor), Norah Bin Aydan (Autor), Mai Alalawi (Autor), Khalid Al Sulaiman (Autor)
• Formato: Libro
• Publicado: Elsevier, 2023-07-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Oseltamivir has been used as adjunctive therapy in the management of patients with COVID-19. However, the evidence about using oseltamivir in critically ill patients with severe COVID-19 remains scarce. This study aims to evaluate the effectiveness and safety of oseltamivir in critically...